Productivity-adjusted life years lost due to type 2 diabetes in Germany in 2020 and 2040.
Burden of disease
Prevalence
Productivity
Projection
Type 2 diabetes
Years of life lost
Journal
Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
13
10
2020
accepted:
21
12
2020
pubmed:
6
3
2021
medline:
23
2
2022
entrez:
5
3
2021
Statut:
ppublish
Résumé
Type 2 diabetes can lead to reduced productivity during working age. We aimed to estimate productive life years lost associated with type 2 diabetes on the individual and population level in Germany in 2020 and 2040, while accounting for future trends in mortality. Based on a mathematical projection model, we estimated age- and sex-specific productivity losses associated with type 2 diabetes during working age (20-69 years) in Germany in 2020 and 2040. Productivity losses in terms of excess mortality (years of life lost, YLL) and reductions in labour force participation, presenteeism and absenteeism (years of productivity lost, YPL) were summed to calculate productivity-adjusted life years (PALY) lost. Input data for the projection were based on meta-analyses, representative population-based studies and population projections to account for future trends in mortality. Compared with a person without type 2 diabetes, mean PALY lost per person with type 2 diabetes in 2020 was 2.6 years (95% CI 2.3, 3.0). Of these 2.6 years, 0.4 (95% CI 0.3, 0.4) years were lost due to YLL and 2.3 (95% CI 1.9, 2.6) years were lost due to YPL. Age- and sex-specific results show that younger age groups and women are expected to lose more productive life years than older age groups and men. Population-wide estimates suggest that 4.60 (95% CI 4.58, 4.63) million people with prevalent type 2 diabetes in 2020 are expected to lose 12.06 (95% CI 10.42, 13.76) million PALY (1.62 million years due to YLL and 10.44 million years due to YPL). In 2040, individual-level PALY lost are projected to slightly decrease due to reductions in YLL. In contrast, population-wide PALY lost are projected to increase to 15.39 (95% CI 13.19, 17.64) million due to an increase in the number of people with type 2 diabetes to 5.45 (95% CI 5.41, 5.50) million. On the population level, a substantial increase in productivity burden associated with type 2 diabetes was projected for Germany between 2020 and 2040. Efforts to reduce the incidence rate of type 2 diabetes and diabetes-related complications may attenuate this increase.
Identifiants
pubmed: 33665686
doi: 10.1007/s00125-021-05409-3
pii: 10.1007/s00125-021-05409-3
pmc: PMC8099797
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1288-1297Références
Breton M-C, Guénette L, Amiche MA, Kayibanda J-F, Grégoire J-P, Moisan J (2013) Burden of diabetes on the ability to work - a systematic review. Diabetes Care 36:740–749. https://doi.org/10.2337/dc12-0354
doi: 10.2337/dc12-0354
pubmed: 23431092
pmcid: 3579337
Seuring T, Archangelidi O, Suhrcke M (2015) The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics 33:811–831. https://doi.org/10.1007/s40273-015-0268-9
doi: 10.1007/s40273-015-0268-9
pubmed: 25787932
pmcid: 4519633
Bommer C, Heesemann E, Sagalova V et al (2017) The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol 5:423–430. https://doi.org/10.1016/S2213-8587(17)30097-9
doi: 10.1016/S2213-8587(17)30097-9
pubmed: 28456416
Cichosz SL, Jensen MH, Hejlesen O (2020) Cognitive impairment in elderly people with prediabetes or diabetes: A cross-sectional study of the NHANES population. Prim Care Diabetes 14:455–459. https://doi.org/10.1016/j.pcd.2019.11.005
doi: 10.1016/j.pcd.2019.11.005
pubmed: 31831376
Ruis C, Biessels GJ, Gorter KJ, van den Donk M, Kappelle LJ, Rutten GEHM (2009) Cognition in the early stage of type 2 diabetes. Diabetes Care 32:1261–1265. https://doi.org/10.2337/dc08-2143
doi: 10.2337/dc08-2143
pubmed: 19366968
pmcid: 2699741
Gosselin E, Lemyre L, Corneil W (2013) Presenteeism and absenteeism: differentiated understanding of related phenomena. J Occup Health Psychol 18:75–86. https://doi.org/10.1037/a0030932
doi: 10.1037/a0030932
pubmed: 23276197
Hex N, Bartlett C, Wright D, Taylor M, Varley D (2012) Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 29:855–862. https://doi.org/10.1111/j.1464-5491.2012.03698.x
doi: 10.1111/j.1464-5491.2012.03698.x
American Diabetes Association (2018) Economic costs of diabetes in the U.S. in 2017. Diabetes Care 41:917–928. https://doi.org/10.2337/dci18-0007
doi: 10.2337/dci18-0007
pubmed: 5911784
pmcid: 5911784
Hird TR, Zomer E, Owen A et al (2019) The impact of diabetes on productivity in China. Diabetologia 62:1195–1203. https://doi.org/10.1007/s00125-019-4875-4
doi: 10.1007/s00125-019-4875-4
pubmed: 31030220
Magliano DJ, Martin VJ, Owen AJ, Zomer E, Liew D (2018) The productivity burden of diabetes at a population level. Diabetes Care 41:979–984. https://doi.org/10.2337/dc17-2138
doi: 10.2337/dc17-2138
pubmed: 29490901
European Commission (2020) European Commission Report on the Impact of Demographic Change. Available from https://ec.europa.eu/info/sites/info/files/demography_report_2020_n.pdf . Accessed 27 Jul 2020
Tönnies T, Röckl S, Hoyer A et al (2019) Projected number of people with diagnosed type 2 diabetes in Germany in 2040. Diabet Med 36:1217–1225. https://doi.org/10.1111/dme.13902
doi: 10.1111/dme.13902
pubmed: 30659656
Bundesministerium für Arbeit und Soziales (BMAS) (2019) Ist die Bevölkerungsentwicklung eine Belastung für das Sozialsystem? Available from https://www.bmas.de/DE/Themen/Rente/Fakten-zur-Rente/Alternde-Gesellschaft/indikator-entwicklung-alten-jugend-gesamtquotienten.html . Accessed 4 Nov 2020
Brinks R, Landwehr S (2014) Age- and time-dependent model of the prevalence of non-communicable diseases and application to dementia in Germany. Theor Popul Biol 92:62–68. https://doi.org/10.1016/j.tpb.2013.11.006
doi: 10.1016/j.tpb.2013.11.006
pubmed: 24333220
Goffrier B, Schulz M, Bätzing-Feigenbaum J (2017) Administrative Prävalenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015. Versorgungsatlas-Bericht 17/03. Available from https://www.versorgungsatlas.de/fileadmin/ziva_docs/79/VA-79-Bericht_Final_V2_20170713.pdf . Accessed 19 Jan 2021 [article in German]
Schmidt C, Reitzle L, Dreß J, Rommel A, Ziese T, Heidemann C (2020) Prevalence and incidence of documented diabetes based on health claims data-reference analysis for diabetes surveillance in Germany. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 63:93–102 [article in German]. https://doi.org/10.1007/s00103-019-03068-9
doi: 10.1007/s00103-019-03068-9
National Diabetes-Surveillance at the Robert Koch Institute (2019) Diabetes in Germany – National Diabetes-Surveillance Report 2019. Available from http://diabsurv.rki.de . Accessed 1 Apr 2020
Rosenbauer J, Neu A, Rothe U, Seufert J, Holl RW (2019) Types of diabetes are not limited to age groups: type 1 diabetes in adults and type 2 diabetes in children and adolescents. J Health Monit 4(2). https://doi.org/10.25646/5987
Bendas A, Rothe U, Kiess W et al (2015) Trends in incidence rates during 1999-2008 and prevalence in 2008 of childhood type 1 diabetes mellitus in Germany–model-based national estimates. PLoS One 10:e0132716. https://doi.org/10.1371/journal.pone.0132716
doi: 10.1371/journal.pone.0132716
pubmed: 26181330
pmcid: 4504467
Federal Statistical Office (Destatis) (2019) 14th coordinated population projection. Available from https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Bevoelkerungsvorausberechnung/Publikationen/Downloads-Vorausberechnung/bevoelkerung-deutschland-2060-5124202199014.html . Accessed 28 Jul 2020
Carstensen B, Rønn PF, Jørgensen ME (2020) Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996–2016. BMJ Open Diabetes Res Care 8:e001071. https://doi.org/10.1136/bmjdrc-2019-001071
doi: 10.1136/bmjdrc-2019-001071
pubmed: 32475839
pmcid: 7265004
Gregg EW, Cheng YJ, Srinivasan M et al (2018) Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 391:2430–2440. https://doi.org/10.1016/S0140-6736(18)30314-3
doi: 10.1016/S0140-6736(18)30314-3
pubmed: 29784146
Magliano DJ, Islam RM, Barr ELM et al (2019) Trends in incidence of total or type 2 diabetes: systematic review. BMJ 366:l5003
doi: 10.1136/bmj.l5003
Heidemann C, Scheidt-Nave C (2017) Prevalence, incidence and mortality of diabetes mellitus in adults in Germany – A review in the framework of the Diabetes Surveillance. Journal of Health Monitoring 2:98–121
Federal Statistical Office (Destatis) Quality of employment - Number of leave days actually taken. Available from https://www.destatis.de/DE/Themen/Arbeit/Arbeitsmarkt/Qualitaet-Arbeit/Dimension-2/genommene-Urlaubstage.html . Accessed 28 Jul 2020
Bommer C, Sagalova V, Heesemann E et al (2018) Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care 41:963–970. https://doi.org/10.2337/dc17-1962
doi: 10.2337/dc17-1962
pubmed: 29475843
Goldman N (1994) Social factors and health: the causation-selection issue revisited. Proc Natl Acad Sci U S A 91:1251–1255
doi: 10.1073/pnas.91.4.1251
Kröger H, Pakpahan E, Hoffmann R (2015) What causes health inequality? A systematic review on the relative importance of social causation and health selection. Eur J Pub Health 25:951–960. https://doi.org/10.1093/eurpub/ckv111
doi: 10.1093/eurpub/ckv111
Tatulashvili S, Fagherazzi G, Dow C, Cohen R, Fosse S, Bihan H (2020) Socioeconomic inequalities and type 2 diabetes complications: A systematic review. Diabetes Metab 46:89–99. https://doi.org/10.1016/j.diabet.2019.11.001
doi: 10.1016/j.diabet.2019.11.001
pubmed: 31759171
Sørensen J, Ploug UJ (2013) The cost of diabetes-related complications: registry-based analysis of days absent from work. Economics Research International 2013:618039
doi: 10.1155/2013/618039
Fu AZ, Qiu Y, Radican L, Wells BJ (2009) Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care 32:2187–2192. https://doi.org/10.2337/dc09-1128
doi: 10.2337/dc09-1128
pubmed: 19729528
pmcid: 2782975
Ng YC, Jacobs P, Johnson JA (2001) Productivity losses associated with diabetes in the U.S. Diabetes Care 24:257–261. https://doi.org/10.2337/diacare.24.2.257
doi: 10.2337/diacare.24.2.257
pubmed: 11213875
Weinstein G, Maillard P, Himali JJ et al (2015) Glucose indices are associated with cognitive and structural brain measures in young adults. Neurology 84:2329–2337. https://doi.org/10.1212/WNL.0000000000001655
doi: 10.1212/WNL.0000000000001655
pubmed: 25948725
pmcid: 4464744